SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001123292-16-001997
Filing Date
2016-03-18
Accepted
2016-03-17 17:39:31
Documents
1
Group Members
ATHYRIUM CAPITAL HOLDINGS, LLCATHYRIUM CAPITAL MANAGEMENT, LPATHYRIUM OPPORTUNITIES ASSOCIATES II GP LLCATHYRIUM OPPORTUNITIES ASSOCIATES II LPJEFFREY A. FERRELL

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G aegerion13g-03182016.htm SC 13G 247774
  Complete submission text file 0001123292-16-001997.txt   249600
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85739 | Film No.: 161513433
SIC: 2834 Pharmaceutical Preparations

Mailing Address 530 FIFTH AVENUE, FLOOR 25 NEW YORK NY 10036
Business Address 530 FIFTH AVENUE, FLOOR 25 NEW YORK NY 10036 212-402-6925
Athyrium Opportunities II Acquisition LP (Filed by) CIK: 0001629077 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G